COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,286 Articles (22,759 medRxiv, 8,527 bioRxiv)

Most recent first Previous |  Page 2982: Articles 29811-29820  | Next

Mapping the Burden of COVID-19 in the United States
Miller, I. F., Becker, A. D., Grenfell, B. T., Metcalf, C. J. E.
10.1101/2020.04.05.20054700 — Posted: 2020-04-11
Prediction on Covid-19 epidemic for different countries: Focusing on South Asia under various precautionary measures
Paul, A., Chatterjee, S., Bairagi, N.
10.1101/2020.04.08.20055095 — Posted: 2020-04-11
On the corona infection model with contact restriction
Mimkes, J., Janssen, R.
10.1101/2020.04.08.20057588 — Posted: 2020-04-11
Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City
Petrilli, C. M., Jones, S. A., Yang, J., Rajagopalan, H., O'Donnell, L. F., Chernyak, Y., Tobin, K., Cerfolio, R. J., Francois, F., Horwitz, L. I.
10.1101/2020.04.08.20057794 — Posted: 2020-04-11 Discussion: Onsite | Offsite
Self-collection: an appropriate alternative during the SARS-CoV-2 pandemic
Wehrhahn, M. C., Robson, J., Brown, S., Bursle, E., Byrne, S., New, D., Chong, S., Newcombe, J. P., Sivertsen, T., Hadlow, N.
10.1101/2020.04.09.20057901 — Posted: 2020-04-11
Testing the association between blood type and COVID-19 infection, intubation, and death
Zietz, M., Tatonetti, N. P.
10.1101/2020.04.08.20058073 — Posted: 2020-04-11 Discussion: Onsite | Offsite
Applying the unified models of ecology to forecast epidemics, with application to Covid-19
Loberg, S. W., Lehman, C.
10.1101/2020.04.07.20056754 — Posted: 2020-04-11
Treatment with ACE-inhibitors is associated with less severe disease with SARS-Covid-19 infection in a multi-site UK acute Hospital Trust
Bean, D., Kraljevic, Z., Searle, T., Bendayan, R., Pickles, A., Folarin, A., Roguski, L., Noor, K., Shek, A., o'gallagher, K., Zakeri, R., Shah, A., Teo, J., Dobson, R. J.
10.1101/2020.04.07.20056788 — Posted: 2020-04-11 Discussion: Onsite
Introductions and early spread of SARS-CoV-2 in the New York City area
Gonzalez-Reiche, A. S., Hernandez, M. M., Sullivan, M., Ciferri, B., Alshammary, H., Obla, A., Fabre, S., Kleiner, G., Polanco, J., Khan, Z., Alburquerque, B., van de Guchte, A., Dutta, J., Francoeur, N., Melo, B. S., Oussenko, I., Deikus, G., Soto, J., Sridhar, S. H., Wang, Y.-C., Twyman, K., Kasarskis, A., Altman, D. R., Smith, M., Sebra, R., Aberg, J., Krammer, F., Garcia-Sarstre, A., Luksza, M., Patel, G., Paniz-Mondolfi, A., Gitman, M., Sordillo, E. M., Simon, V., van Bakel, H.
10.1101/2020.04.08.20056929 — Posted: 2020-04-11 Discussion: Offsite
Modeling the impact of human mobility and travel restrictions on the potential spread of SARS-CoV-2 in Taiwan
Chang, M.-C., Kahn, R., Li, Y.-A., Lee, C.-S., Buckee, C. O., Chang, H.-H.
10.1101/2020.04.07.20053439 — Posted: 2020-04-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).